Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Fosamax (alendronate sodium)Tablets
Company:  Merck Research Laboratories
Application No.:  020560, S015
Approval Date: 11/24/1999

 

Date created: April 24, 2003

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-